Rituximab is a recombinant human lgG1 monoclonal antibody against human CD20. Rituximab is produced by Chinese hamster ovary cells. Rituximab is a glycoprotein.
Rituximab is a genetically engineered chimeric murine/human monoclonal antibody directed against the CD20 antigen found on the surface of normal and malignant B lymphocytes. The antibody is an IgG1 kappa immunoglobulin containing murine light and heavy-chain variable region sequences and human constant region sequences.
苏州锦骊生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
张经理